Despite progesterone receptor affinity, spironolactone is not associated with meningioma development: A population-based cohort study. JAAD. 2025.
Published: 19 February 2025| Version 1 | DOI: 10.17632/pb8zy8mks2.1
Contributor:
Li-Chi ChenDescription
Supplemental methods and results.
Files
Categories
Dermatology, Pharmacoepidemiology, Meningioma, Safety, Acne, Alopecia, Androgen Receptor, Progesterone Receptor